Mike Bismuth

Mike Bismuth

Auto-generated profile, based on publicly available information

Mike Bismuth

Tel Aviv University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
MBMike Bismuth
Mike Bismuth
SKSharon Katz
Sharon Katz
TMTamar Mano
Tamar Mano
RARamona Aronovich
Ramona Aronovich
DHDov Hershkovitz
Dov Hershkovitz
Tali IlovitshTali Ilovitsh
Tali Ilovitsh
Scaling down the size of microbubble contrast agents to the nanometer level holds the promise for noninvasive cancer therapy. However, the small size of nanobubbles limits the obtained bioeffects as a result of ultrasound cavitation, when operating near the nanobubble resonance frequency. Here we show that coupled with low energy insonation at a frequency of 80 kHz, well below the resonance frequency of these agents, nanobubbles serve as noninvasive therapeutic warheads that trigger potent mechanical effects in tumors following a systemic injection. We demonstrate these capabilities in tissue mimicking phantoms, where a comparison of the acoustic response of micro- and nano-bubbles after insonation at a frequency of 250 or 80 kHz revealed that higher pressures were needed to implode the nanobubbles compared to microbubbles. Complete nanobubble destruction was achieved at a mechanical index of 2.6 for the 250 kHz insonation vs. 1.2 for the 80 kHz frequency. Thus, the 80 kHz insonation complies with safety regulations that recommend operation below a mechanical index of 1.9. In vitro in breast cancer tumor cells, the cell viability was reduced to 17.3 ± 1.7% of live cells. In vivo, in a breast cancer tumor mouse model, nanobubble tumor distribution and accumulation were evaluated by high frequency ultrasound imaging. Finally, nanobubble-mediated low frequency insonation of breast cancer tumors resulted in effective mechanical tumor ablation and tumor tissue fractionation. This approach provides a unique theranostic platform for safe, noninvasive and low energy tumor mechanotherapy.

23 October 2023 in Nanoscale
Verified
Journal Article
Closed access
PDF file
MBMike Bismuth
Mike Bismuth
MEMichal Eck
Michal Eck
Tali IlovitshTali Ilovitsh
Tali Ilovitsh
We developed an improved sonoporation method using nanobubbles, offering potential for noninvasive uses. Our results confirmed that low frequency insonation yields sonoporation outcomes comparable to those achieved with targeted microbubbles.

9 October 2023 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
Keren Tchelet KarlinskyKeren Tchelet Karlinsky
Keren Tchelet Karlinsky
MBMike Bismuth
Mike Bismuth
RARamona Aronovich
Ramona Aronovich
Tali IlovitshTali Ilovitsh
Tali Ilovitsh
Objective: Nanoscale ultrasound contrast agents show promise as alternatives for diagnostics and therapies due to their enhanced stability and ability to traverse blood vessels. Nonetheless, their reduced size limits echogenicity. This study introduces a nanobubble frequency mixing ultrasound imaging method. This method enhances nanobubble imaging by capitalizing on their nonlinear acoustic response to dual-frequency excitation. Methods: A single broadband transducer (L12-3v) controlled by a programmable ultrasound system was used to transmit a dual-frequency single-cycle wavefront. The frequency mixing effect enabled simultaneous transducer capture of nanobubble-generated sum and difference frequencies in real time without the need for additional hardware or post-processing, by substituting the single-frequency wavefront in a standard contrast harmonic pulse inversion imaging protocol, with the dual-frequency wavefront. Results: Optimization experiments were conducted in tissue mimicking phantoms. Among the dual-frequency combinations that were tested, the highest contrast was obtained using 4&8 MHz. The nanobubble contrast improved with increased mechanical index, and achieved a maximal contrast improvement of 8.4±0.5 dB compared to 4 MHz pulse inversion imaging. In a breast cancer tumor mouse model, tumor imaging after a systemic nanobubble injection indicated that the resulted in a higher contrast for the frequency mixing method over standard single-frequency imaging. The contrast was improved by 3.4 ± 1.7, 4.8 ± 1.8, and 6.3 ± 1.6 dB for mechanical indices of 0.04, 0.08, and 0.1, respectively. Conclusion: Nonlinear frequency mixing significantly improved the nanobubble contrast, which facilitated their imaging in-vivo. Significance: This study offers a new avenue to enhance ultrasound imaging utilizing nanobubbles, potentially leading to advancements in other diagnostic applications.

4 January 2026 in bioRxiv
Verified
Preprint
Open access
GLGaya Lamm
Gaya Lamm
TGTal Grutman
Tal Grutman
MBMike Bismuth
Mike Bismuth
Tali IlovitshTali Ilovitsh
Tali Ilovitsh
Accurate temperature monitoring during cryoablation, a minimally invasive technique that destroys tissue locally by forming an ice ball around an inserted cryoprobe, is vital for achieving complete ablation while protecting surrounding tissue. We present a dense slowness-shift imaging method that estimates local speed-of-sound changes from ultrasound B-mode images using optical flow. This single-transducer, image-based approach enables mapping of spatial temperature change without requiring additional hardware. Cryoablation experiments in a tissue-mimicking phantom and ex vivo turkey breast demonstrated that slowness deviation increases with decreasing temperature. In the phantom, the dependence was linear (α a = -20.70 ηs·m −1 C° −1 ), while in turkey breast it presented an exponential relationship (α t = 34.04×exp(0.075(-ΔT)) ηs·m −1 C° −1 ). The algorithm detected sub-degree temperature variations and accurately tracked cooling down to -39.4 ± 5.6 °C. This work demonstrates the feasibility of ultrasound-based, noninvasive temperature monitoring during cryoablation, providing a scalable, real-time alternative to existing invasive or high-cost thermal assessment techniques.

11 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SZSaar Gotshal Zahavi
Saar Gotshal Zahavi
MBMike Bismuth
Mike Bismuth
TBTiran Bercovici
Tiran Bercovici
Tali IlovitshTali Ilovitsh
Tali Ilovitsh
Tracking immune cells deep within living tissue remains a fundamental challenge due to the diffraction-limited resolution of ultrasound imaging and the inability to resolve dense cellular populations. Here, we introduce an intracellular super-resolution ultrasound imaging framework based on stochastic phase-changing nanodroplets (NDs) and ultrasound localization microscopy (ULM). We engineer ~170 nm perfluorocarbon NDs that undergo reversible, stochastic liquid-gas transitions under acoustic excitation, generating temporally sparse "blinking" signals. Leveraging the intrinsic endocytic activity of macrophages, these NDs are internalized, enabling intracellular contrast generation independent of vascular flow. We validate this approach across imaging scales, from controlled phantoms and in vitro systems to in vivo tumor models, demonstrating robust intracellular blinking, high cell viability, and consistent super-resolution reconstruction in dense cellular environments. The stochastic blinking of internalized NDs provides the temporal separation required to localize individual sources, overcoming a central limitation of conventional ULM. Following systemic administration, ND-labeled macrophages are tracked in vivo after homing to the liver, where super-resolution ULM resolves cellular distributions with a spatial resolution of 26.3 ± 3.2 μm, corresponding to a 6.1-fold improvement over diffraction-limited imaging. This work establishes a previously unexplored paradigm for ultrasound-based intracellular super-resolution imaging, enabling non-invasive visualization of immune cell organization in deep tissue. By introducing spatiotemporally programmable intracellular contrast, this approach expands ultrasound beyond vascular imaging toward functional cellular imaging, with broad implications for immunology, diagnostics, and cell-based therapies.

22 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TBTiran Bercovici
Tiran Bercovici
MBMike Bismuth
Mike Bismuth
MGMeir Goldsmith
Meir Goldsmith
Dan PeerDan Peer
Dan Peer
Tali IlovitshTali Ilovitsh
Tali Ilovitsh
Stimulus-responsive nanomedicines promise spatiotemporally controlled therapy, yet most systems rely on passive delivery and lack precise, externally programmable activation while maintaining clinical compatibility. Here we engineer sub-200 nm, perfluorocarbon (PFC)-core nanodroplets (NDs) that integrate efficient core drug loading, physiological stability, and acoustically programmable activation within a single nanoscale agent. These NDs are fabricated using microfluidic nanoassembly to achieve controlled size and composition, and are designed to encapsulate fluorinated payloads directly within the liquid core. Upon exposure to a sequential dual-frequency ultrasound (US) paradigm, the NDs undergo acoustic droplet vaporization followed by low-frequency cavitation, enabling spatially confined mechanical disruption and on-demand payload release within clinically relevant acoustic limits. These properties are engineered to overcome physicochemical barriers in solid tumors, including dense extracellular matrix and restricted drug penetration. This approach achieves enhanced payload release and induces potent mechanochemical cytotoxicity in vitro. In vivo, NDs exhibit prolonged circulation and tumor accumulation, while US activation drives substantial tissue fractionation, control drug release, and increases subsequent nanoparticle uptake. When applied to a solid tumor model, this combined mechanochemical strategy improves tumor control and significantly extends survival compared to either modality alone. These acoustically activatable NDs provide a versatile system for stimulus-responsive, site-targeted drug delivery and mechanical tumor disruption, with strong potential for clinical translation. Graphical